Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Advisors
Partners
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
EXO-Ovarian Cancer Test
Exosome Therapeutics
NeuCA15-3 Test
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
3-Aug-2020
Change in substantial holding
30-Jul-2020
Quarterly Business Update & Appendix 4C
29-Jul-2020
Appendix 2A - Issue of Scheme Shares
28-Jul-2020
BARD1 COMPLETES SIENNA ACQUISITION
28-Jul-2020
SDX: Implementation of Scheme of Arrangement
24-Jul-2020
Appointment of Chief Scientific Officer
29-Apr-2020
Quarterly Activities Report & Appendix 4C
20-Apr-2020
Receipt of R&D Tax Incentive Refund
2-Apr-2020
BARD1 Signs Contract with Griffith University
25-Feb-2020
Half Yearly Report and Accounts
Previous
1
2
3
4
5
Next
